Results

Total Results: 1,175 records

Showing results for "fentanyl".

1. Fentora (fentanyl buccal tablet). | PSNet
   psnet.ahrq.gov/issue/fentora-fentanyl-buccal-tablet
   October 28, 2020 - Government Resource Fentora (fentanyl buccal tablet).

2. Patient Safety Advisory: fentanyl counterfeit prescription medications that contain fentanyl and patient safety. | PSNet
   psnet.ahrq.gov/issue/patient-safety-advisory-fentanyl-counterfeit-prescription-medications-contain-fentanyl-and
   November 16, 2022 - Organizational Policy/Guidelines Patient Safety Advisory: fentanyl counterfeit prescription … medications that contain fentanyl and patient safety. … Patient Safety Advisory: fentanyl counterfeit prescription medications that contain fentanyl and patient … Fentanyl is a high-risk medication, whether prescribed by a health professional or obtained illicitly … Patient Safety Advisory: fentanyl counterfeit prescription medications that contain fentanyl and patient

3. Accidental exposures to fentanyl patches continue to be deadly to children. | PSNet
   psnet.ahrq.gov/issue/fentanyl-patch-can-be-deadly-children
   January 13, 2021 - Fact Sheet/FAQs Accidental exposures to fentanyl patches continue to be deadly to … January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … December 10, 2008 Fentanyl transdermal system (marketed as Duragesic) information.

4. Fentanyl transdermal system (marketed as Duragesic) information. | PSNet
   psnet.ahrq.gov/issue/safety-warnings-regarding-use-fentanyl-transdermal-skin-patches
   August 12, 2015 - Government Resource Fentanyl transdermal system (marketed as Duragesic) information … alerts health care professionals, patients, and their caregivers to the possibility for overdoses of fentanyl … in patients using fentanyl skin patches for pain control. … February 16, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

5. SRDR - Systematic Review Data Repository |
   srdr.ahrq.gov/projects/1654/studies/194661
   January 01, 2015 - Description A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl … citrate in the treatment of dyspnea on exertion in patients with advanced cancer. … Title A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl … citrate in the treatment of dyspnea on exertion in patients with advanced cancer.

6. Leaving a discontinued FentaNYL infusion attached to the patient leads to a tragic error | PSNet
   psnet.ahrq.gov/issue/leaving-discontinued-fentanyl-infusion-attached-patient-leads-tragic-error
   February 10, 2021 - Newspaper/Magazine Article Leaving a discontinued FentaNYL infusion attached to the … tubing and alarm management errors came together to result in the death of patient sedated with fentanyl

7. Computer-assisted continuous infusions of fentanyl during cardiac anesthesia: comparison with a manual method | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
   digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/computer-assisted-continuous
   July 01, 1985 - Computer-assisted continuous infusions of fentanyl during cardiac anesthesia: comparison with a manual … Purpose of Study:  Evaluate two computer-assisted methods of fentanyl infusion. … during cardiac anesthesia were compared with a manual fentanyl administration method. … level system (ratio = 0.99, n = 91) and in the CACI variable fentanyl level system (ratio = 1.08, n … The stable fentanyl level group of patients received significantly more (P less than 0.05) fentanyl than

8. Ongoing, preventable fatal events with fentanyl transdermal patches are alarming! | PSNet
   psnet.ahrq.gov/issue/ongoing-preventable-fatal-events-fentanyl-transdermal-patches-are-alarming
   July 18, 2012 - Newspaper/Magazine Article Ongoing, preventable fatal events with fentanyl transdermal

9. A serious threat to patient safety: the unintended misuse of FentaNYL patches. | PSNet
   psnet.ahrq.gov/issue/serious-threat-patient-safety-unintended-misuse-fentanyl-patches
   January 21, 2009 - Commentary A serious threat to patient safety: the unintended misuse of FentaNYL … A serious threat to patient safety: the unintended misuse of FentaNYL patches. … A serious threat to patient safety: the unintended misuse of FentaNYL patches.

10. CER 220 Evidence Summary: Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-220-analgesics-acute-pain-summary.pdf
    September 01, 2019 - : 6 Mixed: 2 Morphine: 6 Mixed: 2 Morphine: 9 Fentanyl: 1 Fentanyl: 1 Morphine: 3 Ketorolac: 2 … intranasal ketamine and fentanyl in children with limb injuries. … A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate … Morphine versus fentanyl for pain due to traumatic injury in the emergency department. … Effectiveness of prehospital morphine, fentanyl, and methoxyflurane in pediatric patients.

11. Midazolam and fentanyl continuous infusion anesthesia for cardiac surgery: a comparison of computer-assisted versus manual infusion systems | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
    digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/midazolam-and-fentanyl
    June 01, 1993 - Midazolam and fentanyl continuous infusion anesthesia for cardiac surgery: a comparison of computer-assisted … Purpose of Study:  Assess a comparison of computer-assisted midazolam and fentanyl continuous infusion … Intervention:  Continuous infusions of midazolam and fentanyl by a computer-assisted continuous infusion … Mean plasma fentanyl concentrations measured at specific time points were similar between groups. … In the MCI group, the average duration of anesthesia was 246.5 +/- 35.0 minutes, with a mean total fentanyl

12. FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death. | PSNet
    psnet.ahrq.gov/issue/fda-requiring-color-changes-duragesic-fentanyl-pain-patches-aid-safety-emphasizing-accidental
    May 15, 2013 - Press Release/Announcement FDA requiring color changes to Duragesic (fentanyl) pain … October 3, 2022 Fentanyl transdermal system (marketed as Duragesic) information. … August 5, 2015 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

13. SRDR - Systematic Review Data Repository |
    srdr.ahrq.gov/projects/1654
    October 29, 2021 - J. 2020 Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot … Lu C., William W., Pisters K., Eapen G., Fossella F., Amin S., Bruera E. 2016 EffenDys-Fentanyl … R., Piel M., Cornely OA., Nauck F., Voltz R. 2016 Effects of prophylactic subcutaneous fentanyl … citrate in the treatment of dyspnea on exertion in patients with advanced cancer. … Tian C., Wang JY., Wang ML., Jiang B., Zhang LL., Liu F. 2016 Prophylactic Fentanyl Sublingual

14. CHIPRA 218: Section 1, Tables 1 to 5 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-218-section-1-tables-1-5.pdf
    May 01, 2019 - • Ibuprofen • Indomethacin • Ketorolac Tromethamine Nepafenac • Alfentanil Hydrochloride • Fentanyl … Citrate • Meperidine Hydrochloride • Morphine • Morphine Sulfate • Remifentanil Hydrochloride • … Methylnaltrexone Bromide • Flurbiprofen Sodium • Ibuprofen Lysine • Indomethacin Sodium • Meloxicam • Fentanyl

15. Check Your Medicines: Tips for Taking Medicines Safely. | PSNet
    psnet.ahrq.gov/issue/check-your-medicines-tips-taking-medicines-safely
    March 27, 2024 - October 5, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … September 21, 2015 Fentanyl transdermal system (marketed as Duragesic) information.

16. FentaNYL patch fatalities linked to "bystander apathy." We ALL have a role in prevention! | PSNet
    psnet.ahrq.gov/issue/fentanyl-patch-fatalities-linked-bystander-apathy-we-all-have-role-prevention
    May 07, 2014 - Newspaper/Magazine Article FentaNYL patch fatalities linked to "bystander apathy. … December 14, 2022 Leaving a discontinued FentaNYL infusion attached to the patient leads … July 21, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

17. 6 Tips to Avoid Medication Mistakes. | PSNet
    psnet.ahrq.gov/issue/6-tips-avoid-medication-mistakes
    April 08, 2020 - November 13, 2013 FDA requiring color changes to Duragesic (fentanyl) pain patches to … February 20, 2013 Accidental exposures to fentanyl patches continue to be deadly to children … January 26, 2023 Accidental exposures to fentanyl patches continue to be deadly to children … September 21, 2015 Fentanyl transdermal system (marketed as Duragesic) information. … May 21, 2014 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid

18. Assessment of the FDA Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl products. | PSNet
    psnet.ahrq.gov/issue/assessment-fda-risk-evaluation-and-mitigation-strategy-transmucosal-immediate-release
    January 22, 2020 - Assessment of the FDA Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl … Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl … and Mitigation Strategy in preventing inappropriate prescribing of transmucosal immediate-release fentanyl … program revealed that anywhere from 35% to 55% of patients were prescribed transmucosal immediate-release fentanyl … Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl

19. Lock it Up: Medicine Safety in Your Home. | PSNet
    psnet.ahrq.gov/issue/lock-it-medicine-safety-your-home
    April 08, 2020 - April 27, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid … February 20, 2013 Accidental exposures to fentanyl patches continue to be deadly to children … February 21, 2007 Fentanyl transdermal system (marketed as Duragesic) information. … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children … November 18, 2016 Fentanyl transdermal system (marketed as Duragesic) information.

20. Be an Active Member of Your Health Care Team. | PSNet
    psnet.ahrq.gov/issue/be-active-member-your-health-care-team
    April 08, 2020 - April 27, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid … February 20, 2013 Accidental exposures to fentanyl patches continue to be deadly to children … February 21, 2007 Fentanyl transdermal system (marketed as Duragesic) information. … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children … September 21, 2015 Fentanyl transdermal system (marketed as Duragesic) information.